A novel gene delivery system using urothelial tissue engineered neo-organs

Area of Science:

• Biomedical Engineering
• Gene Therapy
• Tissue Engineering

Background:

• Ex vivo gene transfer is effective but reintroducing modified cells in vivo is challenging.
• Tissue engineering offers potential for creating neo-organ systems for in vivo applications.

Purpose of the Study:

• To explore biodegradable polymer scaffolds as a novel system for in vivo gene therapy.
• To develop a urothelial cell delivery vehicle for gene transfer using tissue engineering.

Main Methods:

• Normal human urothelial cells were cultured and seeded onto biodegradable polymer scaffolds.
• The cell-polymer constructs were transfected with reporter gene constructs (PGL3-luc, pCMV-luc, pCMV beta-gal).
• Transfected scaffolds were implanted in athymic mice, with tissue retrieval at various time points (0-7 days).

Main Results:

• Reporter gene assays showed sustained luciferase expression from day 1 to day 7, peaking at day 5.
• X-gal and beta-galactosidase antibody assays confirmed successful transfection of the urothelial cells.
• The cell-polymer constructs formed organ-like structures in vivo.

Conclusions:

• Biodegradable polymer scaffolds serve as effective urothelial cell delivery vehicles for gene transfer.
• Engineered urothelial tissue demonstrates functional gene expression in vivo.
• This approach represents a safe and effective method for urothelial tissue engineered gene transfer.